-, DNL593 Placebo, Sterile lyophilisate in single-dose glass vials, -, FAMOTIDINE
DNLI-H-0001
Phase 2 small_molecule active
Quick answer
-, DNL593 Placebo, Sterile lyophilisate in single-dose glass vials, -, FAMOTIDINE for Frontotemporal Dementia (FTD) is a Phase 2 program (small_molecule) at Denali Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Denali Therapeutics
- Indication
- Frontotemporal Dementia (FTD)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active